| Product Code: ETC7550906 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Phosphodiesterase (PDE) Inhibitors Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, 2021 & 2031F |
3.3 India Phosphodiesterase (PDE) Inhibitors Market - Industry Life Cycle |
3.4 India Phosphodiesterase (PDE) Inhibitors Market - Porter's Five Forces |
3.5 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Types, 2021 & 2031F |
3.6 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Indication, 2021 & 2031F |
3.7 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Phosphodiesterase (PDE) Inhibitors Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of erectile dysfunction and other related medical conditions in India |
4.2.2 Growing awareness about the availability and benefits of phosphodiesterase (PDE) inhibitors |
4.2.3 Technological advancements leading to the development of more effective PDE inhibitors |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approval in India |
4.3.2 Presence of alternative treatment options for erectile dysfunction and related conditions |
5 India Phosphodiesterase (PDE) Inhibitors Market Trends |
6 India Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1 India Phosphodiesterase (PDE) Inhibitors Market, By Types |
6.1.1 Overview and Analysis |
6.1.2 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Types, 2021- 2031F |
6.1.3 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specific, 2021- 2031F |
6.1.4 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Non-Specific, 2021- 2031F |
6.1.5 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Phosphodiesterase (PDE) Inhibitors Market, By Indication |
6.2.1 Overview and Analysis |
6.2.2 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Congestive Heart Failure, 2021- 2031F |
6.2.3 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Erectile Dysfunction, 2021- 2031F |
6.2.4 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Inflammatory Airways Disease, 2021- 2031F |
6.2.5 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.3 India Phosphodiesterase (PDE) Inhibitors Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.4 India Phosphodiesterase (PDE) Inhibitors Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Specialty Clinics, 2021- 2031F |
6.4.5 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Phosphodiesterase (PDE) Inhibitors Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 India Phosphodiesterase (PDE) Inhibitors Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 India Phosphodiesterase (PDE) Inhibitors Market Import-Export Trade Statistics |
7.1 India Phosphodiesterase (PDE) Inhibitors Market Export to Major Countries |
7.2 India Phosphodiesterase (PDE) Inhibitors Market Imports from Major Countries |
8 India Phosphodiesterase (PDE) Inhibitors Market Key Performance Indicators |
8.1 Patient adherence rate to PDE inhibitors treatment |
8.2 Number of new product launches in the PDE inhibitors market in India |
8.3 Percentage of healthcare professionals recommending PDE inhibitors as a treatment option |
9 India Phosphodiesterase (PDE) Inhibitors Market - Opportunity Assessment |
9.1 India Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Types, 2021 & 2031F |
9.2 India Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Indication, 2021 & 2031F |
9.3 India Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By End User, 2021 & 2031F |
9.5 India Phosphodiesterase (PDE) Inhibitors Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Phosphodiesterase (PDE) Inhibitors Market - Competitive Landscape |
10.1 India Phosphodiesterase (PDE) Inhibitors Market Revenue Share, By Companies, 2024 |
10.2 India Phosphodiesterase (PDE) Inhibitors Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here